...
首页> 外文期刊>Biological & pharmaceutical bulletin >Neutralizing Antibody Evasion Ability of Adenovirus Vector Induced by the Bioconjugation of Methoxypolyethylene Glycol Succinimidyl Propionate (MPEG-SPA).
【24h】

Neutralizing Antibody Evasion Ability of Adenovirus Vector Induced by the Bioconjugation of Methoxypolyethylene Glycol Succinimidyl Propionate (MPEG-SPA).

机译:甲氧聚乙二醇丙酸琥珀酰亚胺基丙酸酯(MPEG-SPA)生物缀合诱导的腺病毒载体的中和抗体逃避能力。

获取原文
获取原文并翻译 | 示例

摘要

Although adenovirus vectors (Ad) which possesses high transduction efficiency are widely used for gene therapy in animal models, clinical use is very limited. One of the main reason is that nearly 80% of human beings possess anti-Ad antibodies. In this study, we tried to modify Ad with methoxypolyethylene glycol (MPEG) activated by succinimidyl propionate, and, the neutralizing antibody evasion ability of PEGylated Ad was evaluated. The results demonstrated that PEG-Ad showed stronger protection ability against anti-Ad neutralizing antibody compared to that with unmodified-Ad. Considering there are many people carrying neutralizing antibody against Ad and readministration of Ad was necessary for treating chronic diseases, this strategy, which was also applicable to other vectors, can be used for developing improved vectors.
机译:尽管具有高转导效率的腺病毒载体(Ad)被广泛用于动物模型的基因治疗,但是临床用途非常有限。主要原因之一是近80%的人类拥有抗Ad抗体。在这项研究中,我们试图用丙二酸琥珀酰亚胺基酯活化的甲氧基聚乙二醇(MPEG)修饰Ad,并评估了聚乙二醇化Ad的中和抗体逃避能力。结果表明,与未修饰的Ad相比,PEG-Ad显示出更强的抗Ad中和抗体的保护能力。考虑到有许多人携带针对Ad的中和抗体,Ad的重新给药对于治疗慢性疾病是必要的,因此该策略(也适用于其他载体)可用于开发改良的载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号